Depression symptoms (PHQ-2, cutoff ≥ 3), wave 3 | ||||||||
Crudea | Model 1b | Model 2c | Model 3d | |||||
OR | 95% CI | OR | 95% CI | OR | 95% CI | OR | 95% CI | |
Generalised trust, wave 2 | 0.49*** | 0.41, 0.58 | 0.64*** | 0.53, 0.77 | 0.66*** | 0.54, 0.80 | ||
Institutional trust, wave 2 | 0.60*** | 0.50, 0.71 | 0.79* | 0.65, 0.96 | 0.92 | 0.75, 1.13 | ||
Anxiety symptoms (GAD-2, cutoff ≥ 3), wave 3 | ||||||||
Crudea | Model 1b | Model 2c | Model 3d | |||||
OR | 95% CI | OR | 95% CI | OR | 95% CI | OR | 95% CI | |
Generalised trust, wave 2 | 0.57*** | 0.48, 0.67 | 0.72*** | 0.60, 0.87 | 0.74** | 0.61, 0.91 | ||
Institutional trust, wave 2 | 0.66*** | 0.56, 0.79 | 0.83* | 0.69, 1.00 | 0.93 | 0.76, 1.13 | ||
Depression and anxiety symptoms (PHQ-4, scale 0–12), wave 3 | ||||||||
Crudea | Model 1b | Model 2c | Model 3d | |||||
b | 95% CI | b | 95% CI | b | 95% CI | b | 95% CI | |
Generalised trust, wave 2 | -1.19*** | -1.40, -0.97 | -0.73*** | -0.94, -0.51 | -0.71*** | -0.95, -0.48 | ||
Institutional trust, wave 2 | -0.77*** | -1.00, -0.53 | -0.30* | -0.54, -0.06 | -0.04 | -0.30, 0.22 |